| Cannabidiol for the treatment of psychosis in Parkinson’s disease AW Zuardi, JAS Crippa, JEC Hallak, JP Pinto, MHN Chagas, ... Journal of Psychopharmacology 23 (8), 979-983, 2009 | 435 | 2009 |
| Effects of cannabidiol in the treatment of patients with Parkinson’s disease: an exploratory double-blind trial MHN Chagas, AW Zuardi, V Tumas, MA Pena-Pereira, ET Sobreira, ... Journal of Psychopharmacology 28 (11), 1088-1098, 2014 | 405 | 2014 |
| Quantifying brain iron deposition in patients with Parkinson's disease using quantitative susceptibility mapping, R2 and R2 JHO Barbosa, AC Santos, V Tumas, M Liu, W Zheng, EM Haacke, ... Magnetic resonance imaging 33 (5), 559-565, 2015 | 282 | 2015 |
| Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a case series. MHN Chagas, AL Eckeli, AW Zuardi, MA Pena‐Pereira, ... Journal of Clinical Pharmacy & Therapeutics 39 (5), 2014 | 276 | 2014 |
| Salivary α-synuclein and DJ-1: potential biomarkers for Parkinson's disease I Devic, HJ Hwang, JS Edgar, K Izutsu, R Presland, C Pan, DR Goodlett, ... Brain 134 (7), e178-e178, 2011 | 269 | 2011 |
| Role of nitric oxide on motor behavior EAD Bel, FS Guimarães, M Bermũdez-Echeverry, MZ Gomes, ... Cellular and molecular neurobiology 25, 371-392, 2005 | 145 | 2005 |
| Effects of acute cannabidiol administration on anxiety and tremors induced by a Simulated Public Speaking Test in patients with Parkinson’s disease SM De Faria, D de Morais Fabrício, V Tumas, PC Castro, MA Ponti, ... Journal of Psychopharmacology 34 (2), 189-196, 2020 | 119 | 2020 |
| Nitric oxide synthase inhibition attenuates L-DOPA-induced dyskinesias in a rodent model of Parkinson's disease FE Padovan-Neto, MB Echeverry, V Tumas, EA Del-Bel Neuroscience 159 (3), 927-935, 2009 | 99 | 2009 |
| Frontal assessment battery in a Brazilian sample of healthy controls: normative data R Beato, V Amaral-Carvalho, HC Guimarães, V Tumas, CP Souza, ... Arquivos de neuro-psiquiatria 70, 278-280, 2012 | 98 | 2012 |
| Effects of cannabidiol on amphetamine-induced oxidative stress generation in an animal model of mania SS Valvassori, G Elias, B De Souza, F Petronilho, F Dal-Pizzol, ... Journal of Psychopharmacology 25 (2), 274-280, 2011 | 96 | 2011 |
| The accuracy of diagnosis of major depression in patients with Parkinson's disease: a comparative study among the UPDRS, the geriatric depression scale and the Beck depression … V Tumas, GGR Rodrigues, TLA Farias, JAS Crippa Arquivos de Neuro-psiquiatria 66, 152-156, 2008 | 93 | 2008 |
| Cannabinoids in neurology–Brazilian Academy of Neurology S Brucki, NA Frota, P Schestatsky, AH Souza, VN Carvalho, ... Arquivos de neuro-psiquiatria 73, 371-374, 2015 | 80 | 2015 |
| Validity of a Brazilian version of the Zung self-rating depression scale for screening of depression in patients with Parkinson's disease MHN Chagas, V Tumas, SR Loureiro, JEC Hallak, C Trzesniak, ... Parkinsonism & related disorders 16 (1), 42-45, 2010 | 80 | 2010 |
| High frequency of sleep disorders in Parkinson’s disease and its relationship with quality of life MA Sobreira-Neto, MA Pena-Pereira, EST Sobreira, MHN Chagas, ... European neurology 78 (5-6), 330-337, 2017 | 78 | 2017 |
| Is cannabidiol the ideal drug to treat non-motor Parkinson’s disease symptoms? JAS Crippa, JEC Hallak, AW Zuardi, FS Guimarães, V Tumas, ... European archives of psychiatry and clinical neuroscience 269, 121-133, 2019 | 74 | 2019 |
| The prevalence and correlation of non-motor symptoms in adult patients with idiopathic focal or segmental dystonia N Novaretti, ALN Cunha, TC Bezerra, MAP Pereira, DS de Oliveira, ... Tremor and Other Hyperkinetic Movements 9, 2019 | 72 | 2019 |
| Rating scales for behavioral symptoms in Huntington's disease: critique and recommendations TA Mestre, E van Duijn, AM Davis, AC Bachoud‐Lévi, M Busse, ... Movement Disorders 31 (10), 1466-1478, 2016 | 66 | 2016 |
| Validation and internal consistency of Patient Health Questionnaire-9 for major depression in Parkinson's disease MHN Chagas, V Tumas, GR Rodrigues, JP Machado-de-Sousa, AS Filho, ... Age and ageing 42 (5), 645-649, 2013 | 60 | 2013 |
| Use of the frontal assessment battery in evaluating executive dysfunction in patients with Huntington’s disease GR Rodrigues, CP Souza, RS Cetlin, DS de Oliveira, M Pena-Pereira, ... Journal of neurology 256, 1809-1815, 2009 | 60 | 2009 |
| Validity of the Brazilian version of the freezing of gait questionnaire JAO Baggio, MB Curtarelli, GR Rodrigues, V Tumas Arquivos de neuro-psiquiatria 70, 599-603, 2012 | 59 | 2012 |
